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Summary
The humoral immune response to protein antigens is
composed of a rapid low-affinity IgM antibody re-
sponse followed by an IgG response exhibiting higher
affinity. Here, we demonstrate that Lsc, a protein that
regulates G protein-coupled-receptor signaling and
RhoA activation, is required by B lymphocytes for
the antigen-specific IgM antibody response to a pro-
tein antigen. We further show that in lsc–/– mice, MZB
cells are selectively affected such that naive and
in vivo-activated MZB cells migrate toward sphingo-
sine-1-phosphate at increased proportions but release
inefficiently from integrin ligands. Consequently,
lsc–/– MZB cells do not traffick appropriately in an im-
mune response and do not contribute to the TD anti-
body response. These data demonstrate that Lsc reg-
ulates the migration and adhesion of MZB cells, and
this regulation appears to be required for these cells
to contribute to the antibody response to TD antigens.
Introduction
In secondary lymphoid tissue, B lymphocytes are orga-
nized into follicles next to the T cell area of the periarter-
iolar lymphoid sheath (PALS) and, in the spleen of
mammals, are also distributed in the marginal zone
surrounding the white pulp cords. Signals transmitted
via G protein-coupled receptors (GPCRs) expressed by
B lymphocytes and specific for chemokines and lyso-
phospholipids are responsible for guiding these cells to
the follicles and marginal zone, respectively (Cyster,
2005). Follicular positioning of B cells relies on CXCR5
chemokine-receptor signaling in response to the
CXCL13 chemokine expressed within follicles (Ansel
et al., 2000; Forster et al., 1996). In contrast, B cells are
guided to the marginal zone by signals delivered via
the interaction of the sphingosine-1-phosphate (S1P)
lysophospholipid with the S1P1 receptor (Cinamon
et al., 2004). In the marginal zone, B cells are retained
by adhesion of the aLb2 (leukocyte-function adhesion
molecule-1; LFA-1) and a4b1 (very late antigen-4; VLA-4)
integrins to intracellular-adhesion molecule-1 (ICAM-1)
and vascular cell-adhesion molecule-1 (VCAM-1), respec-
tively, (Lu and Cyster, 2002).
In the primary response to protein antigens, antigen-
specific IgM is first observed within 2 days after antigen
exposure (Jacob et al., 1991; Liu et al., 1991). Subse-
*Correspondence: torresr@njc.orgquently, antibodies of isotypes other than IgM (e.g.,
IgG) are produced and dominate the immune response.
Regardless of which antibody isotype is elicited, a phys-
ical interaction between antigen-specific B and T lym-
phocytes is required for antibody production against
a protein (T-dependent; TD) antigen and is facilitated
by the coordinated movement of antigen-activated B
and T cells to a common microenvironment.
Marginal-zone B (MZB) cells, together with B1 B cells,
are responsible for the T cell-independent production of
antibodies against blood-borne particulate polymeric
antigens (Lopes-Carvalho and Kearney, 2004; Martin
et al., 2001; Wardemann et al., 2002). However, the role
of MZB cells in the TD antibody response is less clear.
These cells have been shown to be particularly efficient
in presenting antigens to T cells (Attanavanich and Kear-
ney, 2004), indicating that these cells potentially contrib-
ute to the TD antibody response. In addition, cell-trans-
fer experiments have demonstrated that MZB cells are
capable of producing the majority of the IgM against
a TD antigen, whereas follicular B cells are the predom-
inant source of antigen-specific IgG (Song and Cerny,
2003).
A general feature of cell movement is the GPCR-
induced activation of the Rho GTPase family members,
Cdc42, Rac, and Rho (Etienne-Manneville and Hall,
2002; Ridley et al., 2003). In leukocyte cell migration,
chemoattractant signaling via Gai-associated GPCRs
leads to spatially-restricted activation of Rac and
Cdc42 at the leading edge resulting in lamellipodia or fi-
lopodia extensions, respectively. At the trailing edge,
actin-myosin filament contraction and integrin release
culminate in cell-rear retraction and depend on the lo-
calized activation of RhoA. In contrast to Gai-mediated
GPCR signaling of chemotaxis, Ga12/13-mediated
GPCR signaling in a neutrophil cell line has been shown
to be important for Rho activation at the trailing edge (Xu
et al., 2003).
A direct signaling pathway between GPCRs and the
RhoA is provided by the hematopoietically-restricted
Lsc protein that harbors domains encoding regulator
of G protein signaling (RGS) and Rho guanine nucleotide
exchange factor (RhoGEF) activity. RGS family proteins
typically enhance the intrinsic GTPase activity of spe-
cific Ga subunits, thereby negatively regulating the sig-
naling by associated GPCRs (Ross and Wilkie, 2000).
In contrast, RhoGEF family proteins activate Rho
GTPases by stimulating the exchange of GTP for
GDP. The RGS-like domain of the Lsc human ortho-
log, p115RhoGEF, is specific for Ga12 family members
(Chen et al., 2003; Kozasa et al., 1998; Wells et al.,
2002) and is predicted to attenuate signaling by GPCRs
associated with Ga12/13-containing heterotrimeric G
proteins. Moreover, association of Ga13 with p115Rho-
GEF stimulates Lsc RhoGEF activity specific for RhoA
(Hart et al., 1998). Thus, the function of Lsc can be envi-
sioned to attenuate Ga12/13-mediated GPCR signaling
and subsequently activate RhoA signaling.
Previously, an Lsc-deficient mouse mutant was
shown to have a deficiency in MZB cells and depressed
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gens (Girkontaite et al., 2001). Here, using a considerably
different strategy to generate a null lsc allele in embry-
onic stem cells, we show that Lsc is required for the pri-
mary IgM antibody response to a TD antigen but is not
necessary for the accompanying IgG response. We fur-
ther demonstrate that migration to S1P and integrin-me-
diated release is selectively impaired with lsc–/– MZB
lymphocytes in vitro and in vivo. As a result, lsc–/– MZB
cells do not contribute to the antibody response to TD
antigens.
Results
Generation of lsc–/– Mice
Given the multiple functional domains of Lsc and the rel-
atively large lsc locus, we designed a gene targeting ap-
proach that exploits Cre/loxP technology to generate an
lsc null allele by deleting approximately 4.9 kb encod-
ing the putative regulatory region and first exon of lsc
in C57BL/6-derived embryonic stem cells (Figure S1 in
the Supplemental Data available with this article online).
The gene encoding lsc is closely linked to cd79a, the
gene that encodes the Ig-a signaling component of the
B cell antigen-receptor complex. Thus, it was important
to assess Ig-a expression and function in lsc–/– animals.
Western-blot and flow-cytometric analysis of Ig-a are
shown in Figure S1 and demonstrate intact Ig-a expres-
sion. Importantly, we find that the B cell antigen receptor
expressed by lsc–/– and wild-type B cells signal equiva-
lently with respect to calcium mobilization, proliferation,
and in vivo activation as measured by antigen-specific
upregulation of the CD86 activation antigen (data not
shown).
Depending on anatomical location, the numbers of
lsc–/– peripheral B cells were variably reduced (Figure
S2A) from 20% (lymph nodes) to 80% (peritoneal B1
cells) of wild-type levels. In the spleen, lsc–/– B cell num-
bers were diminished to approximately 50% of wild-type
levels. The numbers of lsc–/– T cells were on average
slightly reduced in spleen and slightly increased in
lymph nodes, but these differences were not significant.
Peripheral lymph nodes and Peyer’s patches were
found at equivalent numbers in Lsc mutants relative to
the wild-type. Histological and flow-cytometric analyses
revealed the presence of both follicular and marginal-
zone B cell populations (Figure S2). The proportion of
mutant B cell populations was similar to that found in
the wild-type and, thus, decreased on average in total
cell number by approximately 50%. A previously gener-
ated Lsc mutant also harbored significantly reduced
numbers of marginal-zone B cells but normal numbers
of follicular B cells (Girkontaite, et al., 2001). The basis
for these discordant findings is not clear but likely
reflects the significantly different genetic backgrounds
of mice examined or the distinct targeting strategies
used to alter the lsc locus or both (Supplemental Data).
lsc–/–Mice Do Not Generate an IgM Primary Antibody
Response to Model TD Antigen
Despite reduced numbers of mature peripheral B cells,
lsc–/– animals mounted IgM and IgG3 antibody re-
sponses comparable to the wild-type against the TI
type 2 antigen, 4-hydroxy-3-nitrophenylacetyl (NP) hap-ten coupled to Ficoll (NP-Ficoll; Figure 1A). Because the
marginal zone and B1 B cell populations are responsible
for the TI antibody response (Martin et al., 2001), these
data indicate that neither population requires Lsc for
response to a TI antigen.
We next assessed the lsc–/– TD antibody response to
NP-chicken g-globulin (NP-CG). Mutant and wild-type
mice generated equivalent NP-specific IgG1, IgG2a,
and IgG3 antibody responses with respect to magnitude
and kinetics (Figure 1B and data not shown). In contrast,
the lsc–/– antigen-specific IgM antibody response was
significantly and reproducibly reduced to less than
20% of wild-type levels at all time points (Figure 1B).
Similar results were also observed for the IgM response
to immunization with the TD antigen, arsonate coupled
to keyhole limpet hemocyanin (data not shown).
Given that lsc–/– mice were able to mount an IgM re-
sponse to a TI antigen, we considered it unlikely that
lsc–/– B cells were intrinsically impaired in their ability
to produce and secrete IgM. Indeed, when lsc–/– and
wild-type splenocytes were isolated and stimulated in
vitro with LPS, lsc–/– B cells secreted equivalent levels
of IgM compared to wild-type at 2, 5, and 7 days after
stimulation (Figure 1C). Similar results were also ob-
tained with CD43-negatively-enriched splenic B cells
(data not shown). Moreover, mutant and wild-type ani-
mals harbored equivalent levels of (preimmune) serum
IgM and IgG1 (Figure 1C). Thus, by in vitro and in vivo
measure, lsc–/– B cells appear normal in the ability to
produce and secrete IgM.
We conclude that in response to a TD antigen, Lsc is
required for the generation of antigen-specific IgM, but
not IgG. A similar requirement for Lsc is not needed
for the TI antibody response or for in vitro or in vivo
IgM secretion.
Deficiency in the TD IgM Response Is B Cell
Autonomous
Lsc is expressed in all hematopoietic cells examined
(Aasheim et al., 1997; Girkontaite et al., 2001; Hart
et al., 1996; Whitehead et al., 1996). Thus, to determine
which Lsc-deficient cell population(s) contributed to
the diminished IgM primary antibody response, we per-
formed a series of adoptive cell transfers. In initial trans-
fers, we tested the antibody response of mutant or wild-
type B cells in the presence of wild-type T cells. C57BL/6
nude (nu/nu) mice were lethally irradiated and reconsti-
tuted either with wild-type or lsc–/– bone-marrow-
enriched hematopoietic stem cells. Subsequently, mature
wild-type T cells were adoptively transferred to both of
the bone-marrow-reconstituted recipients and immu-
nized with NP-CG. These data (Figure 2A) demonstrate
that athymic mice reconstituted with wild-type B and
T cells mount a significant IgM and IgG antibody re-
sponse. However, even in the presence of wild-type T
cells, lsc–/– B cells produce antigen-specific IgM at lev-
els that are 5-fold reduced compared to wild-type,
whereas antigen-specific IgG1 is only reduced by ap-
proximately 2-fold. Thus, mature wild-type T cells are
unable to restore the Lsc-deficient IgM TD antibody re-
sponse.
To determine whether this was a B cell-autonomous
deficit, we evaluated wild-type or lsc–/– B cells for anti-
body production when responding in either an lsc–/– or
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529Figure 1. lsc–/–antibody response to model TI and TD antigens
(A) TI antibody response of wild-type (open) and lsc–/– (black filled) mice to 5 mg of the TI type 2 antigen, NP-Ficoll. NP-specific IgM (left) and IgG3
(right) are shown in preimmune sera (0) and at days 7 and 10 postimmunization. Representative of three independent immunizations.
(B) TD antibody response to 0.1 mg NP-CG + alum elicited in wild-type (open) and lsc–/– (black filled) mice. NP-specific antibody concentration of
IgM (left) and IgG1 (right) are provided in preimmune (0) sera and at 7, 14, and 21 days postimmunization. Symbols represent individual mice, and
horizontal bars indicate the geometric mean. Representative of over six independent immunizations.
(C) Bar graph is representative of two experiments and shows the amount of IgM secreted into the supernatant of LPS-treated splenocytes after
2, 5, and 7 days of in vitro culture. Control (open) and lsc–/– (black filled) culture supernatants are shown. Scatter plot provides the preimmune
sera levels of IgM and IgG1 from B6 (open) and lsc–/– (black filled) mice. Symbols represent individual mice.wild-type host, respectively. Thus, CD43– splenic B cells
were either purified from IgMb mice (lsc–/– or C57BL/6)
and transferred intravenously into sublethally irradiated
allotype-mismatched (IgMa) B6.C20 recipients or puri-
fied from IgMa B6.C20 mice and transferred into lsc–/– re-
cipients. After transfer conditions were established to
achieve reconstitution of donor B cells toR33% of the
total B cell population (Figure 2B), mice were immunized
with NP-CG and assessed for NP-specific IgM produc-
tion. These data demonstrate that wild-type IgMa B lym-
phocytes in an lsc–/– host environment are competent to
produce antigen-specific IgM and at levels similar to in-
tact wild-type mice (Figure 2C). Thus, Lsc-deficient T
cells or dendritic cells do not impair the ability of wild-
type B cells to mount a substantial TD IgM response.
Transfer of wild-type (IgMb) B cells into a IgMa B6.C20
host results in a similar significant contribution (9%–
60%) by donor B cells to the total antigen-specific IgM
response (Figure 2D). However, in contrast, IgMb lsc–/–
B cells do not contribute significantly (<5%) to the total
NP-specific IgM response in a wild-type background.
The adoptive transfer experiments together establish
that a B cell-autonomous deficit in Lsc results in a signifi-
cantly reducedTD-antigen-specific IgMprimaryresponse.
lsc–/– MZB Cells Display an Elevated
Response to S1P
Lsc harbors RGS activity specific for the Ga12 family
(Chen et al., 2003; Kozasa et al., 1998; Wells et al.,
2002), and of the potential GPCRs that are expressed
by B lymphocytes and signal via Ga12/13, a subfamily ofS1P lysophospholipid receptors also signal RhoA activa-
tion. Furthermore, B cell localization to the marginal zone
and subsequent entry into the B cell follicle have been
shown to depend on S1P GPCR expression (Cinamon
et al., 2004). Thus, given the potential of Lsc to regulate
S1P-receptor signaling, we examined whether the
chemotactic response of Lsc-deficient B lymphocytes
to S1P was altered. As previously reported (Cinamon
et al., 2004), we found that wild-type follicular and MZB
cells migrate toward S1P with follicular B cells respond-
ing in smaller numbers and at lower concentrations com-
pared with MZB cells (Figure 3A). lsc–/– follicular B cells
displayed a similarly weak S1P chemotactic response.
In contrast, a significantly increased proportion of lsc–/–
MZB cells migrated toward high S1P concentrations
(1 mM and above) compared to the wild-type (Figure 3A).
The chemotactic response of Lsc-deficient lympho-
cytes toward the CXCL12, CXCL13, and CCL21 lym-
phoid chemokines was also examined and found to be
comparable to wild-type (data not shown).
These data demonstrate that a deficiency in Lsc re-
sults in elevated numbers of marginal-zone, but not fol-
licular, B cells that are capable of responding to physio-
logical concentrations of S1P found in serum (Allende
et al., 2004; Okajima, 2002). We suggest that in the ab-
sence of Lsc, S1P-receptor signaling is not effectively
attenuated in MZB cells and is consistent with the ability
both of Lsc to accelerate Ga12/13 GTPase activity (Chen
et al., 2003; Kozasa et al., 1998; Wells et al., 2002) and of
S1P to induce the activation of the Lsc human ortholog,
p115RhoGEF, in a cell line (Wells et al., 2001).
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the TD IgM Response
(A) Wild-type T cells do not restore TD IgM re-
sponse. Mature wild-type T cells and hema-
topoietic-enriched bone-marrow stem cells
from wild-type (open) or lsc–/– (black filled)
animals were adoptively transferred to
C57BL/6nu/nu mice and subsequently immu-
nized with NP-CG. At days 7 and 14 post-
immunization, sera were collected and NP-
specific IgM and IgG1 titers were determined.
One of two experiments is shown.
(B) Dot plots provide representative flow-
cytometric analysis of lsc–/– (IgMb) and wild-
type (IgMa) mice reconstituted with wild-
type and lsc–/– splenic B cells, respectively.
(C) NP-specific total (open) IgM and IgMb
(shaded) response of wild-type B6.C20
(IgMa) B cells in IgMb lsc–/– animals. The
IgMa wild-type contribution to the NP re-
sponse in reconstituted mice can be deter-
mined as the difference between total IgM
and IgMb.
(D) Contribution of the NP-specific IgMb do-
nor B cells to the total NP-specific IgM re-
sponse in B6.C20 IgMa hosts. lsc–/– IgMb re-
sponse is shown by black symbols, and
C57BL/6 IgMb response is represented by
open symbols.lsc–/– MZB Cells Do Not Efficiently Resolve
Integrin-Mediated Adhesion
Lsc is a RhoA-specific GEF, and RhoA is important for
facilitating both chemoattractant-induced integrin
adhesion (Giagulli et al., 2004; Laudanna et al., 1996;
Wright et al., 2002) and de-adhesion (Alblas et al.,
2001; Liu et al., 2002; Smith et al., 2003; Worthylake
et al., 2001). Thus, we assessed the expression and
functional activity of the physiologically relevant LFA-1
(aLb2) and VLA-4 (a4b1) integrins (Lo et al., 2003) by
lsc–/– B cells.
Flow-cytometric analysis of the aL (CD11a), a4
(CD49d), and b1 (CD29) integrin subunits revealed that
both lsc–/–marginal-zone and follicular B cells expressedslightly higher levels of these integrin subunits compared
to the respective wild-type populations (data not shown).
Because integrin expression does not necessarily reflect
functional adhesion (Hynes, 2002), the ability of mutant B
cells to adhere to integrin ligands was directly measured
in a static adhesion assay (Figure 4A). These data show
that follicular B cells from wild-type and mutant animals
adhered similarly to ICAM-1, VCAM-1, or a combination
of both ICAM-1 and VCAM-1. MZB cells bound the
same ligands with increased frequency compared to fol-
licular B cells and similar to that previously shown (Lu
and Cyster, 2002). Lsc-deficient MZB cells appeared
comparable to wild-type in adhesion to ICAM-1,
VCAM-1, or both ICAM-1 and VCAM-1.
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integrin-mediated adhesive events, cells were placed
on integrin-ligand-coated plates, incubated for 30 min,
and either evaluated for adhesion or washed and further
incubated in medium for an additional hour before mea-
surement. These data demonstrate that after 90 min of
incubation, lsc–/– MZB cells, but not follicular B cells, re-
main bound to integrin ligands at significantly higher
frequencies compared to wild-type cells (Figure 4B).
Therefore, Lsc-deficient marginal-zone and follicular B
cells are comparable to wild-type cells in establishing
adhesion to integrin ligands, but lsc–/– MZB cells remain
adherent for extended periods relative to control cells.
On integrin-ligand-coated substrates, T lymphocytes
migrate in a random manner by a process that is depen-
dent on myosin light-chain kinase for cell attachment
and RhoA for cell detachment (Smith et al., 2003).
Thus, we considered whether the increased period
with which Lsc-deficient MZB cells bound integrin li-
gands reflected an absence of Lsc RhoGEF activity re-
quired for RhoA-mediated cell detachment. To address
this issue, we used video or time-lapse microscopy to
record the movement of isolated wild-type and lsc–/–
marginal-zone and follicular B cells on surfaces coated
with either BSA or both soluble ICAM-1 and VCAM-1
and in the presence or absence of 1 mM S1P. In contrast
to the transwell assays used for evaluating the directed
migration at the population level (Figure 3), these experi-
Figure 3. Migration to S1P
(A) Transwell migration of wild-type (open) and lsc–/– (filled black) fol-
licular and MZB cells to increasing concentrations of S1P. Values
are mean 6 standard deviation (SD) of at least three experiments.
**, p < 0.01; *, p < 0.05 by Student’s unpaired t test.ments monitor nondirectional migration behavior of sin-
gle cells on integrin-ligand-coated substrate. Here, mi-
gration was considered as the movement of a cell
greater than a 10 mm distance within the recorded
time. These experiments revealed that on a BSA-coated
surface, <5% of control and mutant MZB cells polarized
and moved R10 mm, although in the presence of 1 mM
S1P, this frequency increased at least 3-fold (Table 1).
In contrast, on an ICAM-1 and VCAM-1 surface, signifi-
cantly more wild-type and lsc–/– MZB cells were mobile
(Figure 4C and data not shown) and consistent with
the mobility previously shown for T lymphocytes on
ICAM-1 (Smith et al., 2003). A higher proportion of mu-
tant MZB cells travelled R10 mm compared with
controls although, importantly, there was often no net
distance gained (see below). The addition of S1P in-
creased this frequency similarly for both MZB cell pop-
ulations (Movies S1–S4). The migration of lsc–/– MZB
cells on integrin-ligand-coated surface was often ac-
companied by a more marked polarization compared
to wild-type (Figure 4C and Movies S1–S4). However,
time-lapse and video microscopy revealed that this po-
larization of lsc–/– MZB cells was, rather, an extended
trailing edge resulting from inefficient detachment from
integrin ligand because it was never observed on a
BSA-coated surface (Table 1 and data not shown). In-
deed, the inability of lsc–/– MZB cells to release the trail-
ing edge was often observed to require the retraction of
the extending cell body after it had migrated greater
than 10 mm (Movies S2 and S4). In contrast, wild-type
MZB cells and follicular B cells of either genotype rarely
(<2%) were found to exhibit trailing-edge extensions on
integrin-ligand surfaces (Table 1, Figure 5C and Movies
S1, S3, S4, and S6). Similar extended trailing edges have
previously been described with primary T cells, mono-
cytes, and granulocytes when treated with pharmaco-
logical inhibitors of RhoA (Alblas et al., 2001; Smith
et al., 2003; Worthylake et al., 2001) or T cells expressing
a conformationally active LFA-1 integrin (Semmrich et al.
2005).
These data establish that migrating lsc–/– MZB cells
are impaired in trailing-edge release from integrin-ligand
substrate and are consistent with the extended period
with which mutant MZB cells adhere to integrin ligands.
Together these data demonstrate that Lsc is not re-
quired for the induction of integrin-mediated adhesion
but is necessary for appropriate MZB-cell integrin re-
lease and cell-rear retraction in accord with a role for
Lsc in RhoA activation at the trailing edge.
lsc–/– B Cells Do Not Efficiently Release from the
Marginal Zone during a TD Immune Response
The in vivo response of MZB cells to a specific antigen or
LPS is accompanied by the downregulation of S1P-
receptor expression (Cinamon et al., 2004) and a reduc-
tion in integrin adhesion (Lu and Cyster, 2002) allowing
cell migration into the follicle. To assess whether the ab-
errant lsc–/– MZB cell migration and adhesion would in-
fluence this in vivo immune response, we immunized
wild-type and lsc–/– mice with LPS either alone or with
0.1 mg NP-CG and examined spleens by histology. As
previously shown (Groeneveld et al., 1985; Lu and Cys-
ter, 2002), treatment with LPS alone induced the migra-
tion of all wild-type MZB cells into the B cell follicle within
Immunity
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Resolved by lsc–/– MZB Cells
(A) Adhesion of follicular (left panel) and
marginal-zone (right panel) B cells to BSA,
ICAM-1, VCAM-1, or ICAM-1 and VCAM-1.
Data are shown for three to seven indepen-
dent experiments.
(B) Adhesion of follicular and MZB cells to
ICAM-1- and VCAM-1-coated substrate after
90 min of incubation. C57BL/6 and lsc–/– cells
are represented by open and filled black cir-
cles, respectively, and bars represent mean
values.
(C) Adhesion of sorted B6 and lsc–/– follicular
and MZB cells to ICAM-1- and VCAM-1-
coated plates. Right panels are in the pres-
ence of 1 mM S1P. Representative of three
independent experiments. Original magnifi-
cation 3 40; scale bar represents 10 mm.24 hr, and, as expected, a similar migration of wild-type
MZB cells was also observed with NP-CG + LPS (Figure
5A). In contrast, similar immunizations of lsc–/– animals
revealed that a proportion of MZB cells remain in the
marginal zone 24 hr postimmunization. Thus, lsc–/–
MZB cells do not efficiently release from the marginal
zone in vivo in response to LPS.
To better understand the basis for the in vivo retention
of lsc–/– MZB cells in response to LPS, and to examine
the influence of specific antigen, we exploited transgenic
mice whose follicular and MZB cells are specific for the
NP-coupled antigen. Specifically, B1-8/IEkT mice harbor
a productively rearranged VDJ (B1-8) at the Igh locus
(IghB1-8/+) and inactive Igk loci (IgkIEkT/IEkT), and, conse-
quently, all peripheral B cells express an antigen recep-
tor composed of a B1-8 IgH chain together with diverse
Igl chains (data not shown). The pairing of the B1-8 IgH
chain together with any Igl light chain generates anti-bodies with specificity for the NP hapten (Cumano and
Rajewsky, 1985). Importantly, the proportions of NP-
specific follicular and MZB cells are similar in wild-type
and lsc–/– B1-8/IEkT mice (data not shown).
Wild-type and lsc–/– B-18/IEkT animals were immu-
nized with PBS, LPS, or a relative high (1.0 mg) or low
(0.1 mg) dose of specific antigen (NP-CG), and 15 hr later
splenic B lineage cells were examined ex vivo for their
ability to migrate toward S1P. These data (Figure 5B) re-
veal that, consistent with naive cells in vitro (Figure 3A),
an increased proportion of lsc–/– MZB cells responded to
S1P after PBS treatment compared to control cells. LPS
treatment significantly diminished the response of wild-
type and, to a lesser extent, lsc–/– MZB cells toward S1P,
consistent with LPS-mediated downregulation of S1P-
receptor expression (Cinamon et al., 2004). Immuniza-
tion with high and low doses of specific antigen also
substantially reduced the S1P chemotactic responseTable 1. Nondirectional Migration of C57BL/6 and lsc–/– B Cells
B Cell Population Substrate S1P (1 mM) No. of Cells




wild-type MZ BSA – 47 2.1 n.d.
lsc–/– MZ BSA – 42 4.8 n.d.
wild-type MZ BSA + 43 9.3 n.d.
lsc–/– MZ BSA + 60 15.0 n.d.
wild-type MZ I/V – 75 13.0 (0.7) n.d.
lsc–/– MZ I/V – 109 20.6 (2.6) 29.4
wild-type MZ I/V + 146 18.4 (5.0) 1.4
lsc–/– MZ I/V + 137 28.7 (12.8) 27.0
wild-type FO I/V – 69 17.2 (0.7) n.d.
lsc–/– FO I/V – 71 19.9 (2.5) 1.4
wild-type FO I/V + 65 10.4 (1.8) n.d.
lsc–/– FO I/V + 64 16.0 (0.9) 1.6
n.d. denotes none detected. Data on ICAM-1 and VCAM-1 substrate are from three independent experiments and are represented as average6
SD, and data and on BSA are from two independent experiments and are represented as an average. Calculations of cell movement and ex-
tended trailing edge are described in Experimental Procedures.
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Migrate to B Cell Follicles In Vivo
(A) Immunofluorescence histology of spleen
sections from naive wild-type and lsc–/–
mice and at 24 hr after immunization with
LPS with or without NP-CG (0.1 mg). Sections
are stained for CD3 (green), IgD (red), and IgM
(blue). Representative sections of mice from
three individual immunizations. MZB cells
are IgMhigh and appear blue.
(B) B1-8/IEkT wild-type and lsc–/– mice were
injected intraperitoneally with PBS, LPS
(50 mg), 1 mg, or 0.1 mg NP-CG in alum, and
migration of MZB cells to 1 mM S1P was as-
sessed 15 hr later. Data from three indepen-
dent experiments are shown and are distin-
guished by different symbols.of wild-type MZB cells. Immunization with a high antigen
dose also resulted in a reduction of S1P responsiveness
of lsc–/– MZB cells relative to PBS treatment. However,
lsc–/– MZB cells failed to diminish S1P responsiveness
when immunized with a low dose (0.1 mg) of specific an-
tigen that was equivalent to that used for previous anti-
body responses (Figure 1B). Whether the maintenance
of S1P responsiveness in the absence of Lsc reflects in-
efficient downmodulation of S1P-receptor levels or inef-
fective termination of signaling by the remaining SIP re-
ceptors is under current investigation.
Together these data establish that in vivo exposure to
LPS does not lead to the efficient release of lsc–/– MZB
cells from the marginal zone and correlates with the re-
tention of S1P responsiveness after immunization with
a relatively low dose of specific antigen by lsc–/–, but
not wild-type, MZB cells.
Asplenic and Intact Lsc-Deficient Mice Mount Similar
Antibody Responses
An Lsc deficiency appears to selectively affect the naive
and in vivo-activated migration and adhesion of MZB
cells. Because MZB cells are capable of contributing
to the TD IgM antibody response (Attanavanich and
Kearney, 2004; Phan et al., 2005; Song and Cerny,
2003), we questioned whether the impaired IgM primary
antibody response in lsc–/– mice could be attributed to
the observed differences in MZB cell activity. If so,
one would predict that in the absence of MZB cells,
the IgM antibody response to a TD antigen would bediminished in wild-type animals and unchanged in
lsc–/– animals.
To test this, we splenectomized or sham-treated wild-
type and lsc–/– animals, rested them for 10–14 days dur-
ing which time preimmune serum IgM levels return to
that found in intact animals (data not shown), and subse-
quently immunized these mice with NP-CG. The results
from these experiments are shown in Figure 6 and reveal
that asplenic wild-type mice produce 2–3-fold less anti-
gen-specific IgM and IgG1 1 week after immunization
compared with sham-treated and intact wild-type ani-
mals (Figures 6A and 1B). In contrast to the wild-type,
asplenic and sham-treated lsc–/– mice generated essen-
tially equivalent amounts of antigen-specific IgM and
IgG1 1 week postimmunization (Figure 6). In asplenic an-
imals, the follicular B cells residing in remaining second-
ary lymphoid organs must generate the antibody re-
sponse to NP-CG, assuming that B1 cells in the
peritoneal and pleural cavities do not participate in TD
antibody responses. Thus, any difference in the anti-
body response to protein antigens between asplenic
and intact individuals would be expected to reflect the
absence of MZB cells.
These data strongly suggest that MZB cells do not
contribute to the lsc–/– TD immune response. However,
these experiments also demonstrate that in the absence
of MZB cells, wild-type mice produce reduced but sub-
stantial amounts of antigen-specific IgM and IgG and
indicate that marginal-zone and follicular B cells contrib-
ute to the production of both isotypes, and this is con-
sistent with the previously reported antibody response
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sponse by Wild-Type and lsc–/– Asplenic
and Sham-Treated Mice to a TD Antigen
Scatter plots show the NP-specific IgM (A)
and IgG1 (B) antibody response to NP-CG
by wild-type (open) and lsc–/– (filled black)
splenectomized (left) and sham-treated
(right) mice. The antibody levels of (3–8) indi-
vidual mice are shown, and bars represents
the geometric mean. Antibody response is
shown for three independent experiments.of these cell types (Phan et al., 2005; Song and Cerny,
2003).
Discussion
Data presented here demonstrate that Lsc is important
in regulating MZB cell migration and adhesion and ad-
dress the molecular basis for its role in these processes.
We further show that Lsc is required by B cells for the
production of antigen-specific IgM, but not IgG, against
a TD antigen and that in the absence of Lsc, MZB cells
do not contribute to either response.
Chemoattractant GPCR signaling leads to the dissoci-
ation of active Ga-GTP from the bg heterodimer, and
both Ga and bg subsequently signal through different
pathways that ultimately lead to regulated adhesion
and chemotaxis (Pierce et al., 2002). RhoA activation is
one outcome of this signaling and is likely accomplished
by different signaling pathways (Etienne-Manneville and
Hall, 2002; Ridley et al., 2003). Previous biochemical
studies have demonstrated Lsc to possess both RGS
and RhoGEF functional activities that act on Ga12 family
members (Chen et al., 2003; Kozasa et al., 1998; Wells
et al., 2002) and RhoA (Hart et al., 1998; Kozasa et al.,
1998), respectively. Thus, Lsc negatively regulates
GPCR signaling (RGS activity) and positively regulates
RhoA signaling (RhoGEF activity). In the absence of
Lsc, the loss of the negative regulation of GPCR signal-
ing would be expected to lead to heightened GPCR-me-
diated signals by both Ga12/13 and bg subunits, except
those that proceed via Lsc to activate RhoA. We find
that in the absence of Lsc, MZB cells respond in in-
creased proportions to high concentrations of the S1P
lysophospholipid, express elevated levels of functional
integrins, do not detach efficiently from integrin ligands,
and migrate inappropriately during an immune re-
sponse. Of the S1P receptors expressed by MZB cells
that are potentially regulated by Lsc, S1P3 and S1P4 re-
ceptors have been shown to signal through Ga12/13-
associated heterotrimeric proteins to activate RhoA
(Graler et al., 2003; Windh et al., 1999). S1P3 has been
shown to be the major S1P receptor mediating the che-
motaxis of MZB cells toward S1P (Cinamon et al., 2004).
Because Lsc-deficient cells exhibit enhanced S1P mi-
gration, this would suggest that Lsc regulates S1P3 sig-
naling. However, perturbations in S1P4 signaling, or the
integration of S1P3 and S1P4 signaling, that contributeto lsc–/– MZB cell dysfunction remain possible. Our
data are compatible with the absence of Lsc RGS activ-
ity resulting in an inability of lsc–/– MZB cells to effec-
tively attenuate S1P-induced Ga12/13-associated signal-
ing and are supported by reports that Ga13-derived
signaling is necessary for full migratory responses to
particular stimuli (Offermanns et al., 1997) and dissoci-
ated bg subunits are capable of signaling chemotaxis
(Neptune and Bourne, 1997).
Diverse systems of cell migration have shown that
chemoattractant receptors signal the activation of Rho
family GTPases in a spatially-restricted manner (Etienne-
Manneville and Hall, 2002; Ridley et al., 2003; Xu et al.,
2003). In mammalian cells, Gai-mediated signaling
events activate Cdc42 and Rac at the cell leading edge
and lead to cell polarization and actin polymerization to
form filopodial and lamellipodial protrusions, respec-
tively. However, forward cell movement also requires
the spatially-restricted activation of Rho at the trailing
edge, where it is responsible for contraction of actin/
myosin filaments and cell detachment through release
of integrin-mediated adhesive events. In various hemato-
poietic cell types, including primary T lymphocytes, RhoA
has been shown to be necessary for contraction of actin/
myosin filaments and resolution of integrin-mediated
adhesion events leading to cell-rear retraction (Alblas
et al., 2001; Smith et al., 2003; Worthylake et al., 2001).
In a neutrophil cell line, this spatially-restricted RhoA ac-
tivation was shown to proceed via Ga12/13-mediated sig-
naling (Xu et al., 2003). When placed on an integrin-
ligand-coated surface, Lsc-deficient MZB cells adhere
for extended periods of time and when migrating often
develop an elongated trailing edge consistent with in-
efficient release. Indeed, the extended trailing edge of
Lsc mutant cells is similar to those formed by migrating
primary T cells that are unable to resolve integrin-
mediated adhesion events in the absence of RhoA signal-
ing (Smith et al., 2003) or because of a mutation in the cy-
toplasmic domain of the LFA-1 integrin that prevents effi-
cient resolution of integrin-ligand contacts (Semmrich
et al., 2005). Thus, lsc–/– MZB cells establish integrin-
mediated adhesion but are unable to efficiently resolve
these adhesive events, and this is consistent with the no-
tion that Lsc RhoGEF activates RhoA at the trailing edge.
Because cell movement depends on cell adhesion, the
apparent increased ability of Lsc-deficient MZB cells to
migrate toward S1P in an in vitro transwell assay would
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the regulation of mutant cell adhesion is not impaired.
Together, these data lead us to propose that, in re-
sponse to Ga12/13 signaling, Lsc RGS activity is impor-
tant for attenuating GPCR-mediated migration, whereas
Lsc RhoGEF activity is required for RhoA-mediated ac-
tin/myosin filament contraction, or integrin release, or
both. Importantly, our findings support the model of di-
vergent signaling of compartmentalized Rho family acti-
vation (Xu et al., 2003) and extend this paradigm to pri-
mary B lymphocytes responding to antigen in vivo.
The lsc–/– mutation provides a genetic separation be-
tween the TD IgM antibody response and that of IgG and
other class-switched antibody responses. Similar TD
antibody-response profiles have been observed previ-
ously in Pyk2 tyrosine-kinase-deficient (Pyk2–/–) animals
(Guinamard et al., 2000) and in animals reconstituted
with b1-integrin-deficient (b1–/–) hematopoietic cells
(Brakebusch et al., 2002). Pyk2 has been implicated in
Ga13 signaling to RhoA activation (Shi et al., 2000), and
Pyk2–/– animals lack MZB cells. Although the relation-
ship between Pyk2 and Lsc, if any, is not established,
the decreased TD IgM response in Pyk2 mutants is con-
sistent with impaired signaling from Ga13 to RhoA and
lack of MZB cell participation in the antibody response.
Similarly, given that the regulation of VLA-4 (a4b1) ex-
pression and adhesion is important for MZB cell locali-
zation and subsequent migration into follicles during
an immune response (Cinamon et al., 2004; Lu and Cys-
ter, 2002), the absence of a TD IgM response in b1
–/– re-
constituted animals is also consistent with the notion
that appropriate regulation of integrin-mediated adhe-
sion is necessary for the IgM antibody response.
An Lsc deficiency appears to affect MZB cells to
a much greater extent than follicular B cells and likely re-
flects the increased levels of Lsc expressed by MZB cells
compared to follicular B cells (Girkontaite et al., 2001)
(A.R., J.H., and R.T., unpublished data). However, Lsc
regulation of MZB cell migration and adhesion does not
appear to influence the antibody response to a TI anti-
gen. We attribute this difference to the fact that TI type
2 antigens typically display ordered repetitive epitopes
that are thought to transmit distinct antigen-receptor
signal(s) than that induced by protein (TD) antigens. Pre-
cedence exists for the ability of antigen-receptor signal-
ing to influence chemokine-receptor responsiveness
(Bleul et al., 1998; Casamayor-Palleja et al., 2002; Reif
et al., 2002). Thus, we propose that antigen-receptor sig-
nals resulting from engagement of a repetitive epitope
are sufficient to induce the release and migration of
lsc–/– MZB cells, whereas antigen-receptor signaling fol-
lowing engagement with soluble antigen requires Lsc ac-
tivity for appropriate release and migration. Alternatively,
the MZB cell antibody response to TI antigens may not
require similar marginal-zone emigration. Analysis of
wild-type and lsc–/– MZB cell trafficking in response to
a TI antigen will provide insight into these differences.
Lsc has previously been shown to selectively act on
MZB cells (Girkontaite et al., 2001), and these data sig-
nificantly extend earlier findings by more precisely char-
acterizing how Lsc regulates these cells during migra-
tion and adhesion. In the previous report, MZB cells
were also found at reduced cell numbers and exhibited
an increased capacity to migrate toward mouse serum.We find less of a diminution (reduced 50% versus 33%–
17%) in MZB cell numbers and identify S1P as at least
one of the serum components that mediate this en-
hanced chemoattraction. Further similarities and differ-
ences also exist in the TI and TD immune responses.
Both mutant strains exhibit decreased IgM responses
to both TI and TD antigens, although we find the TI IgM
reduction to be nonsignificant. In addition, our data
demonstrate IgM production to be significantly reduced
throughout the TD response and not just late (day 21) as
previously observed. Perhaps the major discordance
between the two Lsc mutants was observed in the IgG
response to a TD antigen that is equivalent to the wild-
type in our analyses and was considerably diminished
in the previous analysis. Although the basis for these dif-
ferences is not clear, considerably different strategies
were employed to inactivate the lsc locus. Because of
the juxtaposition between the genes encoding Ig-
a and Lsc, we carefully examined a potential influence
of our targeting on cd79a. Analysis of Ig-a expression
and function (Figure S1 and data not shown) demon-
strate that lsc–/– B cells exhibit intact Ig-a functional ac-
tivity and indicate that our phenotype is fully attributable
to the absence of Lsc. On the other hand, significant dif-
ferences also exist in the genetic background of the two
Lsc mouse mutants analyzed. The previous Lsc mutant
was analyzed on a mixed 129 genetic background
(Girkontaite et al., 2001; Threadgill et al., 1997), whereas
the Lsc mutant reported here was generated and main-
tained on a C57BL/6 genetic background. Such differen-
ces in genetic background, when examined with the
same B lineage mutation, have been shown to alter
both B cell development (Hasan et al., 2002) and B cell
antigen-receptor signaling (Poe et al., 2004) and may
account for the discrepant results.
The MZB cells found in the spleen of mammals are
physically (Kraal, 1992) and functionally (Oliver et al.,
1997; Oliver et al., 1999) poised to rapidly respond to
blood-borne antigens and, accordingly, serve an impor-
tant role in dealing with particulate (TI) antigens (Martin
and Kearney, 2002; Martin et al., 2001). Our data demon-
strate that lsc–/– animals exhibit altered regulation of
MZB cell migration and adhesion ex vivo and in vivo
and a selective deficit in the IgM antibody response to
a TD antigen. Analysis of splenectomized animals addi-
tionally indicates that, in the absence of Lsc, MZB cells
do not contribute to this response. However, our data
do not formally demonstrate that the impaired TD IgM re-
sponse is strictly a result of inefficient MZB cell function,
and a role for Lsc in regulating the movement of follicular
B cells during a humoral immune response remains pos-
sible. Indeed, in splenectomized animals, Lsc-deficient
follicular B cells are not able to produce levels of anti-
gen-specific IgM comparable to the wild-type.
Collectively our data indicate that MZB cells are also
important for the rapid initial IgM antibody response to
protein (TD) antigens and that Lsc is required by these
cells for the appropriate regulation of migration and in-
tegrin adhesion to fulfill this function. Thus, the role of
MZB cells in protecting the host likely extends to the
rapid production of antigen-specific IgM to protein anti-
gens, after innate immune mechanisms and prior to the
production of high-affinity, somatically mutated anti-




C57BL/6 (IgMb) mice, B6.C20 mice (C57BL/6 IgMa; gift of Dr. Leo-
nore Herzenberg, Stanford), and B-18/IEkT (IghB-18/+; IgkIEkT/IEkT)
mice were bred and maintained at the National Jewish Biological Re-
source Center. lsc–/– animals were generated in, and bred on,
a C57BL/6 genetic background. Animals were used between 8 and
12 weeks of age, and all manipulations were performed in accor-
dance with the Institutional Animal Care and Use Committee.
Antibodies and Flow-Cytometric Analysis
The monoclonal antibodies (and clones) CD45 (RA3-6B2), CD19
(1D3), IgM (R33-24), IgD (1-3.5), CD3 (500A2), CD4 (GK1.4), CD8
(53.67), CD11a (aL; M17/4), and CD49d (a4; PS/2) were purified in
our laboratory and conjugated to fluorochromes or biotin with stan-
dard protocols. CD23 (B3B4), CD1d (1B1) (eBiosciences), CD21
(7G6), CD29 (b1; Ha2/5) (BD Biosciences), and streptavidin (Molecu-
lar Probes) were purchased directly conjugated. Cell staining was
performed by standard protocols, analysis was performed with
a FACSCalibur (BD), and cell sorting was performed with a MoFlo
(Cytomation, Colorado) cell sorter. All flow-cytometric data were an-
alyzed with FlowJo 4.4.3 software.
Immunizations and Antibody Measurement
C57BL/6 and lsc–/– mice were immunized intraperitoneally with 0.1
mg (or 1.0 mg in some experiments) of (4-hydroxy-3-nitrophenyl)
acetyl-coupled chicken g globulin (NP-CG) (Biosearch Technolo-
gies, California) in Alu-Gel-S (Aluminum hydroxide in PBS; Crescent
Chemical, New York) or 5 mg of NP coupled amino-ethyl-carboxy-
methyl-Ficoll (NP-Ficoll) (Biosearch Technologies) in PBS. In some
experiments, 20–50 mg LPS (Escherichia coli O26;B6) was injected
with or without 100 mg NP-CG. Absolute concentrations of NP-
specific antibodies were determined by a standard ELISA protocol
and the B1-8m, and N1G9 monoclonal antibodies (Cumano and
Rajewsky, 1985) were used as NP-specific standards for IgM and
IgG1, respectively.
Adoptive Cell Transfers
C57BL/6 and lsc–/– B220– CD3– CD11b– ckit+ cells were sorted from
bone marrow and 1.53 105 cells were injected intravenously into ir-
radiated (900 rad) BL/6nu/nu mice. Two weeks after bone-marrow re-
constitution, C57BL/6 lymph-node T cells were enriched by anti-Ig
microbeads and sorted as CD11b– CD19– IgM– cells (>90% purity)
and intravenously injected into athymic recipients at 107 T cells
per mouse. Two weeks later, bone-marrow- and T cell-reconstituted
mice were bled to verify B and T cell reconstitution and immunized
intraperitoneally with 100 mg of NP-CG in Alu-Gel-S.
B6.CB20 (IgHa; H-2b) and lsc–/– (IgHb; H-2b) splenic B cells were
purified by negative enrichment with CD43-microbeads (Miltenyi)
and 107 cells (purity > 85%) injected intravenously into sublethaly ir-
radiated (650 rad) lsc–/– or (700 rad) B6.C20 mice, respectively. Two
weeks after transfer, mice were immunized intraperitoneally with
100 mg of NP-CG in Alu-Gel-S. Sera were examined for total and
allotype (IgMb) NP-specific IgM production.
Chemotaxis Assay
Sphingosine-1-phosphate (Avanti Polar Lipids, Alabama) was resus-
pended as per manufacturer recommendation. Recombinant murine
CXCL12 (SDF-1a), CXCL13 (Peprotech, New Jersey), CCL19 (R&D
Systems), or S1P was added to the bottom well of a 24-well plate
in a total of 500 ml of migration medium (Iscove’s medium supple-
mented with Glutamax, 25 mM Hepes buffer, and 1% fatty-acid-
free BSA). Total splenic cells were depleted of red blood cells and
added to the upper insert of a transwell (5 mm pore; Costar) at a con-
centration of 106 cells/100 ml. For S1P migration assays, splenocytes
were incubated in tissue-culture dishes at 37ºC for 30 min to remove
adherent cells prior to red-blood-cell depletion. After 3 hr incubation
at 37ºC, cells were removed from the upper and lower wells, pooled
(2–6 wells were used for each condition in each experiment), stained
on ice, and analyzed by flow cytometry. For relative cell counts,
a FACScalibur was used to acquire cells for 60 s, at which time at
least 250,000–500,000 cells were collected from upper wells and
20,000–90,000 cells from lower wells. The percent of cells migratinginto the bottom chamber was calculated as (number of cells in lower
well) / (number of cells in lower + upper well) 3 100.
Integrin-Mediated Adhesion and Migration
Adhesion was assayed as previously described (Lu and Cyster,
2002). Briefly, tissue-culture 96-well plates (Costar high binding)
were coated with soluble murine Fc-ICAM-1 (10 mg/ml) and Fc-
VCAM-1 (1 mg/ml) or a mixture of ICAM-1 and VCAM-1 (0.3 and 3.0
mg/ml, respectively; R&D Systems) in carbonate buffer, pH 8.2, for
2 hr at room temperature. Blocking and BSA coating was for 1 hr
at room temperature with 1% solution of denatured fatty-acid-free
BSA in DPBS in the absence of calcium or magnesium. Isolated
splenocytes were incubated on tissue-culture plastic for 30 min at
37ºC, nonadherent cells were collected, and red blood cells were
lysed. Cells were added to wells in quadruplicate and incubated
for 30 min at 37ºC in 5% CO2, and nonadherent cells were subse-
quently removed by gentle washing. Adherent cells were released
by addition of 100 ml DPBS with 5 mM EDTA and incubated on ice
for 15 min. Cells from the four wells were pooled; stained for
CD23, CD21, and CD1d; and counted by flow cytometry. In some ex-
periments, after the 30 min incubation, cells were gently washed,
fresh media were added, and they were incubated for an additional
hour before enumeration.
For video and time-lapse migration microscopy, tissue-culture 96-
well plates were coated with 2% fatty-acid-free BSA or soluble mu-
rine Fc-ICAM-1 and Fc-VCAM-1 (0.3 and 3.0 mg/ml, respectively) in
DPBS without Ca2+ or Mg2+. Plates were subsequently blocked
with 600 ml denatured 1% fatty-acid-free BSA in DPBS without
Ca2+ or Mg2+ for approximately 1 hr at room temperature. Sorted
CD21int. CD1dint. follicular (91%–95% purity) and CD21high CD1dhigh
marginal-zone (71%–87% purity) B cells were added at w2 3 104
cells/well in 100 ml with or without 1 mM S1P and incubated for 20
min at 37ºC at 5% CO2. Subsequently, micrographs were recorded
at 15 or 30 s intervals for an additional 15–20 min. To calculate per-
cent of cell movement, we traced individual cells from time-lapse
and video microscopy, and cells that migrated a distance greater
than 10 mm were calculated as a frequency of total cells that ex-
hibited polarization (thus excluding dead cells). The frequency of
cells with an extended trailing edge was calculated as the number
of cells that exhibited a uropod-like structure that was at least equiv-
alent to the length of the cell body of those cells that traveled greater
than a 10 mm distance.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
two Supplemental Figures, and six Supplemental Movies and are
available with this article online at: http://www.immunity.com/cgi/
content/full/23/5/527/DC1/.
Acknowledgments
We acknowledge Dennis Voelker for assistance in the preparation of
S1P, Josh Loomis for help with cell sorting, Bill Townend for time-
lapse microscopy, and members of the R&R lab for discussion.
The authors also thank Peter Henson and Larry Wysocki for critical
comments and discussion on the manuscript. We thank John Camb-
ier for the gift of anti-Iga reagents, and Katrin Hafen is gratefully ac-
knowledged for assistance in the preliminary analysis of lsc–/– mice.
This work was supported in part by a Cancer Research Institute
training grant (J.H.), the Sandler Program in Asthma Research
(R.T.), and the National Institutes of Health (AI052310 to R.P. and
AI052157 to R.T.).
Received: December 22, 2004
Revised: September 19, 2005
Accepted: September 22, 2005
Published: November 15, 2005
References
Aasheim, H.C., Pedeutour, F., and Smeland, E.B. (1997). Character-
ization, expression and chromosomal localization of a human gene
homologous to the mouse Lsc oncogene, with strongest expression
in hematopoetic tissues. Oncogene 14, 1747–1752.
Lsc Regulates Marginal-Zone B Cell Adhesion
537Alblas, J., Ulfman, L., Hordijk, P., and Koenderman, L. (2001). Activa-
tion of Rhoa and ROCK are essential for detachment of migrating
leukocytes. Mol. Biol. Cell 12, 2137–2145.
Allende, M.L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-
Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C.A., Mandala,
S., et al. (2004). Mice deficient in sphingosine kinase 1 are rendered
lymphopenic by FTY720. J. Biol. Chem. 279, 52487–52492.
Ansel, K.M., Ngo, V.N., Hyman, P.L., Luther, S.A., Forster, R., Sedg-
wick, J.D., Browning, J.L., Lipp, M., and Cyster, J.G. (2000). A che-
mokine-driven positive feedback loop organizes lymphoid follicles.
Nature 406, 309–314.
Attanavanich, K., and Kearney, J.F. (2004). Marginal zone, but not
follicular B cells, are potent activators of naive CD4 T cells. J. Immu-
nol. 172, 803–811.
Bleul, C.C., Schultze, J.L., and Springer, T.A. (1998). B lymphocyte
chemotaxis regulated in association with microanatomic localiza-
tion, differentiation state, and B cell receptor engagement. J. Exp.
Med. 187, 753–762.
Brakebusch, C., Fillatreau, S., Potocnik, A.J., Bungartz, G., Wilhelm,
P., Svensson, M., Kearney, P., Korner, H., Gray, D., and Fassler, R.
(2002). Beta1 integrin is not essential for hematopoiesis but is nec-
essary for the T cell-dependent IgM antibody response. Immunity
16, 465–477.
Casamayor-Palleja, M., Mondiere, P., Verschelde, C., Bella, C., and
Defrance, T. (2002). BCR ligation reprograms B cells for migration
to the T zone and B-cell follicle sequentially. Blood 99, 1913–1921.
Chen, Z., Singer, W.D., Wells, C.D., Sprang, S.R., and Sternweis,
P.C. (2003). Mapping the Galpha13 binding interface of the rgRGS
domain of p115RhoGEF. J. Biol. Chem. 278, 9912–9919.
Cinamon, G., Matloubian, M., Lesneski, M.J., Xu, Y., Low, C., Lu, T.,
Proia, R.L., and Cyster, J.G. (2004). Sphingosine 1-phosphate recep-
tor 1 promotes B cell localization in the splenic marginal zone. Nat.
Immunol. 5, 713–720.
Cumano, A., and Rajewsky, K. (1985). Structure of primary anti-
(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in normal and idio-
typically suppressed C57BL/6 mice. Eur. J. Immunol. 15, 512–520.
Cyster, J.G. (2005). Chemokines, sphingosine-1-phosphate, and cell
migration in secondary lymphoid organs. Annu. Rev. Immunol. 23,
127–159.
Etienne-Manneville, S., and Hall, A. (2002). Rho GTPases in cell biol-
ogy. Nature 420, 629–635.
Forster, R., Mattis, A.E., Kremmer, E., Wolf, E., Brem, G., and Lipp,
M. (1996). A putative chemokine receptor, BLR1, directs B cell mi-
gration to defined lymphoid organs and specific anatomic compart-
ments of the spleen. Cell 87, 1037–1047.
Giagulli, C., Scarpini, E., Ottoboni, L., Narumiya, S., Butcher, E.C.,
Constantin, G., and Laudanna, C. (2004). RhoA and zeta PKC control
distinct modalities of LFA-1 activation by chemokines: Critical role
of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity
20, 25–35.
Girkontaite, I., Missy, K., Sakk, V., Harenberg, A., Tedford, K., Potzel,
T., Pfeffer, K., and Fischer, K.D. (2001). Lsc is required for marginal
zone B cells, regulation of lymphocyte motility and immune re-
sponses. Nat. Immunol. 2, 855–862.
Graler, M.H., Grosse, R., Kusch, A., Kremmer, E., Gudermann, T.,
and Lipp, M. (2003). The sphingosine 1-phosphate receptor S1P4
regulates cell shape and motility via coupling to Gi and G12/13. J.
Cell. Biochem. 89, 507–519.
Groeneveld, P.H., Erich, T., and Kraal, G. (1985). In vivo effects of
LPS on B lymphocyte subpopulations. Migration of marginal zone-
lymphocytes and IgD-blast formation in the mouse spleen. Immu-
nobiology 170, 402–411.
Guinamard, R., Okigaki, M., Schlessinger, J., and Ravetch, J.V.
(2000). Absence of marginal zone B cells in Pyk-2-deficient mice de-
fines their role in the humoral response. Nat. Immunol. 1, 31–36.
Hart, M.J., Sharma, S., elMasry, N., Qiu, R.G., McCabe, P., Polakis,
P., and Bollag, G. (1996). Identification of a novel guanine nucleotide
exchange factor for the Rho GTPase. J. Biol. Chem. 271, 25452–
25458.Hart, M.J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W.D., Gilman,
A.G., Sternweis, P.C., and Bollag, G. (1998). Direct stimulation
of the guanine nucleotide exchange activity of p115 RhoGEF by
Galpha13. Science 280, 2112–2114.
Hasan, M., Polic, B., Bralic, M., Jonjic, S., and Rajewsky, K. (2002).
Incomplete block of B cell development and immunoglobulin pro-
duction in mice carrying the muMT mutation on the BALB/c back-
ground. Eur. J. Immunol. 32, 3463–3471.
Hynes, R.O. (2002). Integrins: Bidirectional, allosteric signaling
machines. Cell 110, 673–687.
Jacob, J., Kassir, R., and Kelsoe, G. (1991). In situ studies of the
primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The
architecture and dynamics of responding cell populations. J. Exp.
Med. 173, 1165–1175.
Kozasa, T., Jiang, X., Hart, M.J., Sternweis, P.M., Singer, W.D., Gil-
man, A.G., Bollag, G., and Sternweis, P.C. (1998). p115 RhoGEF,
a GTPase activating protein for Galpha12 and Galpha13. Science
280, 2109–2111.
Kraal, G. (1992). Cells in the marginal zone of the spleen. Int. Rev.
Cytol. 132, 31–74.
Laudanna, C., Campbell, J.J., and Butcher, E.C. (1996). Role of Rho
in chemoattractant-activated leukocyte adhesion through integrins.
Science 271, 981–983.
Liu, L., Schwartz, B.R., Lin, N., Winn, R.K., and Harlan, J.M. (2002).
Requirement for RhoA kinase activation in leukocyte de-adhesion.
J. Immunol. 169, 2330–2336.
Liu, Y.J., Zhang, J., Lane, P.J., Chan, E.Y., and MacLennan, I.C.
(1991). Sites of specific B cell activation in primary and secondary re-
sponses to T cell-dependent and T cell-independent antigens. Eur.
J. Immunol. 21, 2951–2962.
Lo, C.G., Lu, T.T., and Cyster, J.G. (2003). Integrin-dependence of
lymphocyte entry into the splenic white pulp. J. Exp. Med. 197,
353–361.
Lopes-Carvalho, T., and Kearney, J.F. (2004). Development and se-
lection of marginal zone B cells. Immunol. Rev. 197, 192–205.
Lu, T.T., and Cyster, J.G. (2002). Integrin-mediated long-term B cell
retention in the splenic marginal zone. Science 297, 409–412.
Martin, F., and Kearney, J.F. (2002). Marginal-zone B cells. Nat. Rev.
Immunol. 2, 323–335.
Martin, F., Oliver, A.M., and Kearney, J.F. (2001). Marginal zone and
B1 B cells unite in the early response against T-independent blood-
borne particulate antigens. Immunity 14, 617–629.
Neptune, E.R., and Bourne, H.R. (1997). Receptors induce chemo-
taxis by releasing the betagamma subunit of Gi, not by activating
Gq or Gs. Proc. Natl. Acad. Sci. USA 94, 14489–14494.
Offermanns, S., Mancino, V., Revel, J.P., and Simon, M.I. (1997). Vas-
cular system defects and impaired cell chemokinesis as a result of
Galpha13 deficiency. Science 275, 533–536.
Okajima, F. (2002). Plasma lipoproteins behave as carriers of extra-
cellular sphingosine 1-phosphate: Is this an atherogenic mediator or
an anti-atherogenic mediator? Biochim. Biophys. Acta 1582, 132–
137.
Oliver, A.M., Martin, F., Gartland, G.L., Carter, R.H., and Kearney,
J.F. (1997). Marginal zone B cells exhibit unique activation, prolifer-
ative and immunoglobulin secretory responses. Eur. J. Immunol. 27,
2366–2374.
Oliver, A.M., Martin, F., and Kearney, J.F. (1999). IgMhighCD21high
lymphocytes enriched in the splenic marginal zone generate effector
cells more rapidly than the bulk of follicular B cells. J. Immunol. 162,
7198–7207.
Phan, T.G., Gardam, S., Basten, A., and Brink, R. (2005). Altered
migration, recruitment, and somatic hypermutation in the early
response of marginal zone B cells to T cell-dependent antigen.
J. Immunol. 174, 4567–4578.
Pierce, K.L., Premont, R.T., and Lefkowitz, R.J. (2002). Seven-trans-
membrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639–650.
Poe, J.C., Fujimoto, Y., Hasegawa, M., Haas, K.M., Miller, A.S.,
Sanford, I.G., Bock, C.B., Fujimoto, M., and Tedder, T.F. (2004).
CD22 regulates B lymphocyte function in vivo through both
Immunity
538ligand-dependent and ligand-independent mechanisms. Nat. Immu-
nol. 5, 1078–1087.
Reif, K., Ekland, E.H., Ohl, L., Nakano, H., Lipp, M., Forster, R., and
Cyster, J.G. (2002). Balanced responsiveness to chemoattractants
from adjacent zones determines B-cell position. Nature 416, 94–99.
Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg,
M.H., Borisy, G., Parsons, J.T., and Horwitz, A.R. (2003). Cell migra-
tion: Integrating signals from front to back. Science 302, 1704–1709.
Ross, E.M., and Wilkie, T.M. (2000). GTPase-activating proteins for
heterotrimeric G proteins: Regulators of G protein signaling (RGS)
and RGS-like proteins. Annu. Rev. Biochem. 69, 795–827.
Semmrich, M., Smith, A., Feterowski, C., Beer, S., Engelhardt, B.,
Busch, D.H., Bartsch, B., Laschinger, M., Hogg, N., Pfeffer, K., and
Holzmann, B. (2005). Importance of integrin LFA-1 deactivation for
the generation of immune responses. J. Exp. Med. 201, 1987–1998.
Shi, C.S., Sinnarajah, S., Cho, H., Kozasa, T., and Kehrl, J.H. (2000).
G13alpha-mediated PYK2 activation. PYK2 is a mediator of
G13alpha -induced serum response element-dependent transcrip-
tion. J. Biol. Chem. 275, 24470–24476.
Smith, A., Bracke, M., Leitinger, B., Porter, J.C., and Hogg, N. (2003).
LFA-1-induced T cell migration on ICAM-1 involves regulation of
MLCK-mediated attachment and ROCK-dependent detachment.
J. Cell Sci. 116, 3123–3133.
Song, H., and Cerny, J. (2003). Functional heterogeneity of marginal
zone B cells revealed by their ability to generate both early antibody-
forming cells and germinal centers with hypermutation and memory
in response to a T-dependent antigen. J. Exp. Med. 198, 1923–1935.
Threadgill, D.W., Yee, D., Matin, A., Nadeau, J.H., and Magnuson, T.
(1997). Genealogy of the 129 inbred strains: 129/SvJ is a contami-
nated inbred strain. Mamm. Genome 8, 390–393.
Wardemann, H., Boehm, T., Dear, N., and Carsetti, R. (2002). B-1a B
cells that link the innate and adaptive immune responses are lacking
in the absence of the spleen. J. Exp. Med. 195, 771–780.
Wells, C.D., Gutowski, S., Bollag, G., and Sternweis, P.C. (2001).
Identification of potential mechanisms for regulation of p115
RhoGEF through analysis of endogenous and mutant forms of
the exchange factor. J. Biol. Chem. 276, 28897–28905.
Wells, C.D., Liu, M.Y., Jackson, M., Gutowski, S., Sternweis, P.M.,
Rothstein, J.D., Kozasa, T., and Sternweis, P.C. (2002). Mechanisms
for reversible regulation between G13 and Rho exchange factors.
J. Biol. Chem. 277, 1174–1181.
Whitehead, I.P., Khosravi-Far, R., Kirk, H., Trigo-Gonzalez, G., Der,
C.J., and Kay, R. (1996). Expression cloning of lsc, a novel oncogene
with structural similarities to the Dbl family of guanine nucleotide ex-
change factors. J. Biol. Chem. 271, 18643–18650.
Windh, R.T., Lee, M.J., Hla, T., An, S., Barr, A.J., and Manning, D.R.
(1999). Differential coupling of the sphingosine 1-phosphate recep-
tors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) fam-
ilies of heterotrimeric G proteins. J. Biol. Chem. 274, 27351–27358.
Worthylake, R.A., Lemoine, S., Watson, J.M., and Burridge, K.
(2001). RhoA is required for monocyte tail retraction during transen-
dothelial migration. J. Cell Biol. 154, 147–160.
Wright, N., Hidalgo, A., Rodriguez-Frade, J.M., Soriano, S.F., Mel-
lado, M., Parmo-Cabanas, M., Briskin, M.J., and Teixido, J. (2002).
The chemokine stromal cell-derived factor-1 alpha modulates alpha
4 beta 7 integrin-mediated lymphocyte adhesion to mucosal addres-
sin cell adhesion molecule-1 and fibronectin. J. Immunol. 168, 5268–
5277.
Xu, J., Wang, F., Van Keymeulen, A., Herzmark, P., Straight, A., Kelly,
K., Takuwa, Y., Sugimoto, N., Mitchison, T., and Bourne, H.R. (2003).
Divergent signals and cytoskeletal assemblies regulate self-organiz-
ing polarity in neutrophils. Cell 114, 201–214.
